Precise, controlled aerosols wet or dry: ISAB launches new nebulizer feature
From cystic fibrosis to antibiotics, work on new inhalable biologic therapies is growing. With biologics formulated as liquid solutions, the need for precisely controllable wet, as well as dry, aerosols is crucial. PreciseInhale’s new nebulizer feature meets the need, generating aerosol from liquids—and letting researchers choose to deliver them as either wet or dry aerosols to PreciseInhale’s wide range of exposure modules.“Wet or dry aerosol isn’t really the question,” says ISAB CSO Per Gerde. “Precise aerosols and results—or not. That’s what’s really important for drug developers.”